Biotech Stocks Facing FDA Decision In April

So far this year, 4 novel drugs have been approved in the U.S., including Zulresso. Now, let's take a look at the companies that await a ruling from the FDA in April 2019.

from RTT - Biotech https://ift.tt/2HSGl2E
via IFTTT